by Jake Welch, The National Pulse: Researchers for American pharmaceutical giant Moderna have allegedly halted early-stage clinical trials for its mRNA Epstein-Barr virus vaccine following concerns that an adolescent who participated developed a case of myocarditis, according to a report published by researcher Alex Berenson. Around 150 adolescents and 270 people aged between 18 and 30 have been participating in the vaccine Phase […]
Source